Arkolith/Insider Trading/INBX/Form 4

Viking Global Opportunities Parent GP LLC

10% OwnerInhibrx Biosciences, Inc. (INBX) · full profile →Form 4 · filed Oct 9, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$11.3M
Net Open-Market Flow
-$11.3M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 7, 2025Sell(S)16K$32.25$526K67K
Oct 7, 2025Sell(S)309K$32.25$10.0M1.3M
Oct 7, 2025Sell(S)25K$32.25$808K103K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-25-003555) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML